Skip to main content

News

Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.

News

Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.

Engineered Bacteria Prime Tumors for Selective Elimination

March 4, 2024 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program

Children’s Hospital Los Angeles Study Finds Many Kids With Sickle Cell Anemia Lack Preventative Care

March 4, 2024 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program

NIH Clinical Trial Conducted in Part at Arkansas Children’s Produces First FDA-Approved Treatment for Multiple Severe Food Allergies

February 29, 2024 - Grantee/Partner News

  • Clinical and Translational Science Awards (CTSA) Program
  • Our Impact on Clinical Trials

Repurposed Drug Helps Cells Clear Defective Proteins, Reveals Route to New Therapies

February 29, 2024 - NCATS News

  • Analytical Chemistry

Auranofin, a decades-old drug for rheumatoid arthritis, could point the way to new treatments for diseases like cancer and Alzheimer’s disease.

NCATS-Funded Rare Disease Researchers Provide Key Data, Help Build New Kidney Atlas

February 29, 2024 - NCATS News

  • Our Impact on Rare Diseases
  • Rare Diseases Clinical Research Network (RDCRN)

NEPTUNE’s research has helped us learn more about the biology of both rare and common kidney diseases. It has also led to better ways to diagnose and treat these conditions.

FDA Using AI in Drug Surveillance; Health Systems Move Ahead With AI; RAISE Guidance

February 29, 2024 - Media Coverage

  • Biomedical Data Translator (Translator)

Last updated on June 13, 2024